Eastman Chemical price target raised to $108 from $96 at UBS

UBS analyst Joshua Spector raised the firm’s price target on Eastman Chemical to $108 from $96 and keeps a Buy rating on the shares. Eastman Chemical is well positioned into 2023 and earnings should significantly accelerate thereafter, Spector tells investors in a research note. The analyst sees 4Q22 as a bottom and a number of positive factors leading to modestly higher earnings in 2023.